NEW YORK ( TheStreet) -- Pharmacyclics Incorporated (Nasdaq: PCYC) hit a new 52-week high Thursday as it is currently trading at $27.49, above its previous 52-week high of $26.73 with 365,323 shares traded as of 10:25 a.m. ET. Average volume has been 823,600 shares over the past 30 days. Pharmacyclics has a market cap of $1.25 billion and is part of the health care sector and drugs industry. Shares are up 70% year to date as of the close of trading on Wednesday. Pharmacyclics, Inc. operates as a clinical-stage biopharmaceutical company focusing on discovering, developing, and commercializing small-molecule drugs for the treatment of cancer and immune mediated diseases. The company has a P/E ratio of 106, above the S&P 500 P/E ratio of 17.7.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter